Cytosorbents Corporation (FRA:HQE1)
0.6040
+0.0080 (1.34%)
At close: Dec 5, 2025
Cytosorbents Revenue
Cytosorbents had revenue of $9.49M USD in the quarter ending September 30, 2025, with 10.12% growth. This brings the company's revenue in the last twelve months to $36.98M, up 23.89% year-over-year. In the year 2024, Cytosorbents had annual revenue of $35.59M with 14.51% growth.
Revenue (ttm)
$36.98M
Revenue Growth
+23.89%
P/S Ratio
1.25
Revenue / Employee
$248.18K
Employees
149
Market Cap
39.42M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 35.59M | 4.51M | 14.51% |
| Dec 31, 2023 | 31.08M | -3.60M | -10.39% |
| Dec 31, 2022 | 34.69M | -8.48M | -19.64% |
| Dec 31, 2021 | 43.17M | 2.16M | 5.27% |
| Dec 31, 2020 | 41.00M | 16.06M | 64.35% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |
Cytosorbents News
- 18 days ago - Cytosorbents Corporation 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 18 days ago - Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London - PRNewsWire
- 22 days ago - CytoSorbents Corp (CTSO) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... - GuruFocus
- 22 days ago - Q3 2025 Cytosorbents Corp Earnings Call Transcript - GuruFocus
- 22 days ago - Cytosorbents outlines cash flow breakeven targets for Q1 2026 through workforce and cost restructuring - Seeking Alpha
- 22 days ago - Cytosorbents Corporation (CTSO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Cytosorbents (CTSO) Q3 2025 Earnings Transcript - The Motley Fool
- 22 days ago - CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update - PRNewsWire